Bulgaria
Industry
BMI View: The outlook for pharmaceutical companies operating in Bulgaria is deteriorating. Disagreements between hospitals and the national funding bodies are a key concern for the...
2010-08-16Industry
BMI View: The increase in Bulgaria's health insurance fund goes against the trend in other European countries, where governments are either freezing public healthcare expenditure or...
2010-07-22Industry
BMI View: Bulgaria's over-the-counter (OTC) medicine market should pick up in 2010, following a major deceleration in 2009. Nevertheless, prolonged economic troubles and a maturing...
2010-05-06Companies
Bulgaria's pharmaceutical trade balance is largely in favour of imports, a situation that is reflective of the country's historically minimal manufacturing base and ever-improving access...
2010-05-04BMI has introduced greater clarity to its core views for the Pharmaceuticals & Healthcare. Short-term core views concern the period through to the end of the 2011-2013 patent cliff,...
2010-03-15Industry
Pharmaceutical sales in Bulgaria grew by 8.1% to BGN1.72bn (US$1.25bn) in 2009, according to data released by primary market research firm IMS Health. The expansion, which was only...
2010-02-19Industry
Private health insurance funds look set to gain access to public resources for supplementary medical care, under amendments to Bulgaria's Law on Health Insurance. Long-awaited reforms...
2010-02-02Industry
BMI believes that proposed amendments to Hungary's reimbursement system will place substantial pressure on manufacturers of patented treatments and severely ill patients. Draft amendments...
2010-02-01


